"With India achieving high vaccination rates in 2021 and 2022, coupled with the emergence of new mutant variant strains, the demand for previous vaccines diminished significantly. Consequently, since December 2021, we have stopped the manufacturing and supply of additional doses of Covishiel
In his post on X, Saurabh said, "When most European Nations had banned the use of Covishield vaccine due to side effects in March 2021, Indian Govt continued the use of this vaccine. Now facing heat from Courts in the UK, they have withdrawn the vaccine world over."
Amidst the ongoing ruckus related to Covid vaccines, Misa Bharti, daughter of Rashtriya Janata Dal supremo Lalu Prasad and Grand Alliance candidate from Patliputra Lok Sabha constituency has given a statement regarding the removal of the photo of Prime Minister Narendra Modi from the Coro
Congress leader and former Rajasthan Chief Minister Ashok Gehlot said Congress' manifesto has gained popularity after Prime Minister Narendra Modi criticized it. Lakhs of people have started downloading Congress' manifesto.
An application was moved in the Supreme Court on Wednesday seeking to issue direction to form a medical expert panel to examine Covishield vaccine side effects.
An AstraZeneca spokesperson stated, "Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines."
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, cause TTS."
While addressing the mediapersons in Pune, Adar Poonawala said, "We have produced 5-6 million doses as stock, current demand is zero in all hospitals. Current variants are mild and not severe. Senior citizens can take booster doses as a precaution".
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.